Related Experiment Video
Updated: Jul 5, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingolipid signalling in the cardiovascular system: good, bad or both?
Astrid E Alewijnse1, Stephan L M Peters
1Department of Pharmacology and Pharmacotherapy, Academic Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.
Sphingolipids significantly impact cardiovascular function and disease. Understanding their role and how drugs targeting sphingolipid signaling affect the heart may reveal new treatments for cardiovascular diseases, especially in metabolic syndrome patients.
Area of Science:
- Biochemistry and Pharmacology
- Cardiovascular Research
- Immunology
Background:
- Sphingolipids, including ceramide, sphingosine, and sphingosine-1-phosphate, are crucial signaling molecules in cellular processes.
- The drug FTY720 (Fingolimod), a sphingosine-1-phosphate receptor agonist, has spurred research into sphingolipid roles in immunity and other organs.
- FTY720's observed transient decrease in heart rate raises questions about drug-induced cardiovascular effects via sphingolipid pathways.
Purpose of the Study:
- To explore the pharmacological properties of drugs targeting sphingolipid signaling and their impact on cardiovascular function.
- To determine if modulating sphingolipid pathways could offer therapeutic strategies for cardiovascular diseases.
- To investigate the dual role (beneficial or detrimental) of sphingolipids in cardiovascular disease, particularly in the context of metabolic syndrome.
Main Methods:
- Review of existing literature on sphingolipid metabolism and signaling.
- Analysis of studies investigating the cardiovascular effects of FTY720 and related compounds.
- Examination of the link between sphingolipids, metabolic syndrome, and cardiovascular pathologies.
Main Results:
- Sphingolipid signaling pathways are intricately involved in various cardiovascular functions.
- Drugs targeting sphingolipid pathways, like FTY720, can influence heart rate and potentially other cardiovascular parameters.
- The metabolic syndrome, characterized by obesity, hypertension, and diabetes, is associated with altered sphingolipid profiles and increased heart disease risk.
Conclusions:
- Sphingolipids play a complex role in cardiovascular health and disease, acting as both protective and detrimental factors depending on context.
- Targeting sphingolipid signaling represents a potential therapeutic avenue for cardiovascular diseases.
- Further research is needed to elucidate specific sphingolipid actions and optimize drug development for cardiovascular applications.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Types of Signaling Molecules
Types of Signaling Molecules
Asymmetric Lipid Bilayer
Cell-surface Signaling
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
